Ascendis Health (JSE:ASC) Buyback Yield % : -20.79 (As of Jun. 08, 2024)

View and export this data going back to 2013. Start your Free Trial

What is Ascendis Health Buyback Yield %?

Buyback yield is the net repurchase of shares outstanding over the market capital of the company. It is a measure of shareholder return.

Ascendis Health's current buyback yield was -20.79%.

Ascendis Health Buyback Yield % Historical Data

The historical data trend for Ascendis Health's Buyback Yield % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Ascendis Health Buyback Yield % Chart

Ascendis Health Annual Data

Trend

Jun14

Jun15

Jun16

Jun17

Jun18

Jun19

Jun20

Jun21

Jun22

Jun23

Buyback Yield %

Get a 7-Day Free Trial

0.24

0.64

-24.57

Ascendis Health Semi-Annual Data
	Dec13	Jun14	Dec14	Jun15	Dec15	Jun16	Dec16	Jun17	Dec17	Jun18	Dec18	Jun19	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23
Buyback Yield %	Get a 7-Day Free Trial															-	1.02	-	-50.03	-

Competitive Comparison of Ascendis Health's Buyback Yield %

For the Drug Manufacturers - Specialty & Generic subindustry, Ascendis Health's Buyback Yield %, along with its competitors' market caps and Buyback Yield % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Ascendis Health's Buyback Yield % Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Ascendis Health's Buyback Yield % distribution charts can be found below:

* The bar in red indicates where Ascendis Health's Buyback Yield % falls into.

Ascendis Health Buyback Yield % Calculation

Buyback yield is a measure of shareholder return.

Ascendis Health's Buyback Yield for the fiscal year that ended in Jun. 2023 is calculated as

Buyback Yield	=	Net Issuance of Stock			/	Market Cap
	=	- (Repurchase of Stock	+	Issuance of Stock)	/	Market Cap
	=	- (0	+	101.53)	/	413.1897
	=	-24.57%

Ascendis Health's annualized Buyback Yield for the quarter that ended in Jun. 2023 is calculated as

Buyback Yield	=	Net Issuance of Stock		(Annualized)			/	Market Cap
	=	- (Repurchase of Stock	+	Issuance of Stock)	*	Annualized Factor	/	Market Cap
	=	- (0	+	0)	*	2	/	413.1897
	=	0.00%

In calculating the annualized semi-annual data, the Repurchase of Stock and Issuance of Stock data used here is two times the semi-annual (Jun. 2023) data.

Ascendis Health Buyback Yield % Related Terms

Thank you for viewing the detailed overview of Ascendis Health's Buyback Yield % provided by GuruFocus.com. Please click on the following links to see related term pages.

Ascendis Health (JSE:ASC) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Ascendis Health Ltd (JSE:ASC) » Definitions » Buyback Yield %

Comparable Companies

Traded in Other Exchanges

N/A

Address

1 Carey Street, Wynberg, Sandton, GT, ZAF, 2090

Website

https://www.ascendishealth.com

Ascendis Health is a drug manufacturer that produces and distributes health products for the human, animal, and plant markets. It has a portfolio of brands and products and owns recognized trademarks in the pharmaceutical and consumer health markets. Ascendis Health has five operating segments: consumer health, pharma, medical, animal health, and biosciences. The pharma division is the contributor to revenue and is further divided into Pharma Africa, Remedica, and Farmalider. Pharma includes generic manufacturing and distribution and over-the-counter medicine manufacturing and distribution. The company's revenue is split between South Africa and Europe and is diversified across currencies, markets, sales channels, and customer groups.